These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11078915)

  • 41. [Alteration of Fas/FasL gene expression in oral squamous cell carcinoma cell line Tca83 by retinoid acid].
    Guan W; Yu S; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):215-8. PubMed ID: 11812347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Okadaic acid stimulates apoptosis through expression of Fas receptor and Fas ligand in human oral squamous carcinoma cells.
    Goto K; Fukuda J; Haneji T
    Oral Oncol; 2002 Jan; 38(1):16-22. PubMed ID: 11755816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
    Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
    De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
    Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and regulation of Fas and Fas ligand on thyrocytes and infiltrating cells during induction and resolution of granulomatous experimental autoimmune thyroiditis.
    Wei Y; Chen K; Sharp GC; Yagita H; Braley-Mullen H
    J Immunol; 2001 Dec; 167(11):6678-86. PubMed ID: 11714840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors.
    Frankel B; Longo SL; Ryken TC
    Acta Neuropathol; 1999 Oct; 98(4):363-6. PubMed ID: 10502041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
    Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
    J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FAS ligand expression in inflammatory infiltrate lymphoid cells as a prognostic marker in oral squamous cell carcinoma.
    Peterle GT; Santos M; Mendes SO; Carvalho-Neto PB; Maia LL; Stur E; Agostini LP; Silva CV; Trivilin LO; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
    Genet Mol Res; 2015 Sep; 14(3):11145-53. PubMed ID: 26400345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fas ligand is expressed in normal skin and in some cutaneous malignancies.
    Lee SH; Jang JJ; Lee JY; Kim SY; Park WS; Shin MS; Dong SM; Na EY; Kim KM; Kim CS; Kim SH; Yoo NJ
    Br J Dermatol; 1998 Aug; 139(2):186-91. PubMed ID: 9767230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human Papillomavirus and Epidermal Growth Factor Receptor in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma: Correlation With Dynamic Contrast-Enhanced MRI Parameters.
    Choi YS; Park M; Kwon HJ; Koh YW; Lee SK; Kim J
    AJR Am J Roentgenol; 2016 Feb; 206(2):408-13. PubMed ID: 26797372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alteration of Fas/FasL expression of oral squamous cell carcinoma cell line Tca83 induced by retinoic acid.
    Guan WQ; Yu SF; Gao Y
    Chin J Dent Res; 2000 Dec; 3(4):35-9. PubMed ID: 11314085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas labeling status does not correlate with apoptosis of renal cell carcinoma in vivo.
    Koga F; Arai K; Kamai T; Abe H; Yoshida K
    Anticancer Res; 2001; 21(5):3193-7. PubMed ID: 11848472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression.
    Wang R; Brunner T; Zhang L; Shi Y
    Oncogene; 1998 Sep; 17(12):1503-8. PubMed ID: 9794227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.
    Aschkenazi S; Straszewski S; Verwer KM; Foellmer H; Rutherford T; Mor G
    Biol Reprod; 2002 Jun; 66(6):1853-61. PubMed ID: 12021072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
    Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
    J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
    Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
    Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
    Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
    Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.